FR941230-2-00069 FR941230-2-00046 Paragraph IV.B is intended to enjoin and restrain the defendant hospitals from directly or indirectly utilizing the defendant Classic Care or any other agent to set, maintain or determine any fee of any hospital in the Long Island area. Paragraph IV.C. enjoins and restrains the defendant Classic Care from directly or indirectly entering into any agreement with any hospital in the Long Island area concerning the terms or amounts of any fee charged to a third-party payer; entering into any agreement with any hospital in the Long Island area to hold itself out as an exclusive negotiating agent with any third-party payer; developing, adopting or distributing any fee schedule for use with any third-party payer; and recommending that any hospital withdraw from or refuse to enter into any agreement with any third-party payer. Paragraph IV.D. requires that both the defendant Classic Care and the defendant hospitals terminate any agreement or portion thereof entered into with any other defendant that conditions any actual or possible agreement between a hospital and a third-party payer on the formal or informal approval, review or acquiescence of any other defendant. Paragraph V.A. of the proposed Final Judgment provides that nothing in Paragraph IV. shall prevent a defendant from participating in an integrated joint venture. An integrated joint venture is defined by Paragraph II.E. as a joint agreement in which hospitals that would otherwise be competitors pool resources to provide hospital services and share a substantial risk of adverse financial results. Paragraph V.B. provides a procedure whereby defendants may seek plaintiff's approval for any kind of joint venture not covered by Paragraphs V.A. and II.E. of the proposed Final Judgment. Paragraph VI. permits the defendants to enter into agreements relating to a lawful merger or acquisition. Paragraph VII. affirms that this judgment is not intended to place a limit on the First Amendment rights of defendants to petition federal or state government executive agencies. Paragraph VIII. requires each defendant to maintain an antitrust compliance program. Paragraph VIII. provides that this program at a minimum shall include: A. distributing within 60 days from the entry of this Final Judgment, a copy of this Final Judgment and Competitive Impact Statement to all officers, directors, trustees and administrators; B. notifying within 60 days from the entry of this Final Judgment, all officers, directors, trustees and administrators that the defendant will not be bound by any agreement that requires the approval of the defendant Classic Care or any other defendant hospital in connection with any actual or possible agreement between the defendant and any third-party payer; C. distributing in a timely manner a copy of this Final Judgment and Competitive Impact Statement to any successor corporation or person who succeeds to a position as officer, director, trustee, or administrator; D. holding a briefing annually for all operating officers, directors, and administrators on (1) the meaning and requirements of this Final Judgment including the consequences of non-compliance with this Final Judgment; and (2) the application of the federal antitrust laws to the defendant's activities including potential antitrust concerns raised by hospitals (a) engaging in agreements or arrangements with competitors to set or maintain any fee or to limit discounts on any fee, or (b) engaging in agreements with a competitor to refrain from dealing with a third-party payer; E. obtaining from each operating officer or administrator an annual written certification that he or she has (1) read, understands, and agrees to abide by this Final Judgment; (2) has been advised and understands that noncompliance with this Final Judgment may result in his or her conviction for criminal contempt of court and/or fine and (3) is not aware of any violation of this Final Judgment; F. maintaining for inspection by plaintiff a record of recipients to whom this Final Judgment and Competitive Impact Statement have been distributed and from whom the certification required by Paragraph VIII.E. has been obtained; and G. conducting an audit of its activities within 60 days from the entry of this Final Judgment and annually to determine compliance with this Final Judgment.
